Format

Send to

Choose Destination
Aging Clin Exp Res. 2019 Jan 5. doi: 10.1007/s40520-018-1109-4. [Epub ahead of print]

Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Author information

1
Centre for metabolic bone diseases, University of Sheffield, Sheffield, UK.
2
University of Sheffield Medical School, Sheffield, UK.
3
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.
4
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
5
NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK.
6
University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland.
7
Chair for Biomarkers of Chronic Diseses, Department of Biochemistry, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia. jyr.ch@bluewin.ch.
8
Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium. jyr.ch@bluewin.ch.

Abstract

A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. Osteoporos Int, https://doi.org/10.1007/s00198-018-4704-5 , 2018). This manuscript updates the previous guideline document, published in 2013 (Kanis et al. Osteoporos Int 24:23-57, 2013) and is written from a European perspective. The present article reports and summarizes the main recommendations included in this 2018 guidance document (Fig. 1).

KEYWORDS:

Bone mineral density; Diagnosis of osteoporosis; FRAX; Fracture risk assessment; Health economics; Treatment of osteoporosis

PMID:
30612282
DOI:
10.1007/s40520-018-1109-4

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center